Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Spitzweg

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 19, 2007
Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expressionMichael J Willhauck, Bibi-Rana Sharif Samani, Franz-Josef Gildehaus, et al.
Endocrine-Related Cancer|October 28, 2020
Integrin αvβ3-dependent thyroid hormone effects on tumour proliferation and vascularisationKathrin A Schmohl, Yang Han, Mariella Tutter, et al.
BMC Cancer|June 15, 2019
Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumorsFlorian Bösch, Alexandr V Bazhin, Sabine Heublein, et al.
Journal of Clinical Medicine|October 24, 2020
Distinct Expression Patterns of VEGFR 1-3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic FactorFlorian Bösch, Annelore Altendorf-Hofmann, Sven Jacob, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2015
Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic geneKerstin Knoop, Nathalie Schwenk, Kathrin Schmohl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 10, 2016
Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) GeneSarah Urnauer, Stephan Morys, Ana Krhac Levacic, et al.
Clinical Endocrinology|November 7, 2021
Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case seriesViktoria F Koehler, Carmina T Fuss, Christina M Berr, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 12, 2008
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancerMichael J Willhauck, Bibi-Rana Sharif Samani, Ingo Wolf, et al.
Oncotarget|April 6, 2017
Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) geneKathrin A Schmohl, Aayush Gupta, Geoffrey K Grünwald, et al.
Human Gene Therapy|May 5, 2018
External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene DeliveryChristina Schug, Wolfgang Sievert, Sarah Urnauer, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|August 19, 2007
Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expressionMichael J Willhauck, Bibi-Rana Sharif Samani, Franz-Josef Gildehaus, et al.
Endocrine-Related Cancer|October 28, 2020
Integrin αvβ3-dependent thyroid hormone effects on tumour proliferation and vascularisationKathrin A Schmohl, Yang Han, Mariella Tutter, et al.
BMC Cancer|June 15, 2019
Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumorsFlorian Bösch, Alexandr V Bazhin, Sabine Heublein, et al.
Journal of Clinical Medicine|October 24, 2020
Distinct Expression Patterns of VEGFR 1-3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic FactorFlorian Bösch, Annelore Altendorf-Hofmann, Sven Jacob, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2015
Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic geneKerstin Knoop, Nathalie Schwenk, Kathrin Schmohl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 10, 2016
Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) GeneSarah Urnauer, Stephan Morys, Ana Krhac Levacic, et al.
Clinical Endocrinology|November 7, 2021
Medullary thyroid cancer with ectopic Cushing's syndrome: A multicentre case seriesViktoria F Koehler, Carmina T Fuss, Christina M Berr, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 12, 2008
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancerMichael J Willhauck, Bibi-Rana Sharif Samani, Ingo Wolf, et al.
Oncotarget|April 6, 2017
Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) geneKathrin A Schmohl, Aayush Gupta, Geoffrey K Grünwald, et al.
Human Gene Therapy|May 5, 2018
External Beam Radiation Therapy Enhances Mesenchymal Stem Cell-Mediated Sodium-Iodide Symporter Gene DeliveryChristina Schug, Wolfgang Sievert, Sarah Urnauer, et al.
Pageof 13